BeiGene · 17 hours ago
Senior Manager, Instructional Designer GXP Training
BeOne Medicines USA is a rapidly growing company focused on fighting cancer. They are seeking a Senior Manager, Instructional Designer to lead the development of engaging and scalable learning experiences that support global quality excellence in compliance and continuous improvement.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Lead the Full Instructional Design Lifecycle
Design High-Impact QMS Learning Experiences
Integrate Learning Science and Behavior Change Models
Collaborate Across Global Quality and Learning Teams
Develop and Deliver Multi-Modal Learning Content
Evaluate and Continuously Improve Training Effectiveness
Qualification
Required
Bachelor's degree and 7+ years of Instructional Design, adult Learning and GXP Training Curriculum experience required
Master's degree and 5+ years of Instructional Design, adult Learning and GXP Training Curriculum experience required
3 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
Experience with mobile learning solutions, knowledge or LMS and LXP platforms
Proficient in Microsoft, Articulate suite, Synthesia, Vyond, Cognota, Degreed, WalkMe
Benefits
Medical
Dental
Vision
401(k)
FSA/HSA
Life Insurance
Paid Time Off
Wellness
Company
BeiGene
BeiGene is a global oncology company.
H1B Sponsorship
BeiGene has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (32)
2023 (39)
2022 (40)
2021 (28)
2020 (16)
Funding
Current Stage
Public CompanyTotal Funding
$6.79BKey Investors
Hillhouse InvestmentAmgenCITIC Capital Holdings,Hillhouse Investment
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M
Leadership Team
Recent News
2026-01-07
Company data provided by crunchbase